Glenmark Life Sciences Limited IPO
Glenmark Life Sciences Limited was a mainboard IPO, offered at ₹695–₹720 per share to raise ₹1,514 crore. The issue was subscribed 44.17× overall (QIBs 36.97×, NIIs 122.54×, retail 14.63×). It listed on 6 Aug 2021 at ₹750 and closed its first day at ₹748, a listing gain of +4.0% versus the ₹720 issue price. It now trades around ₹1,415 (+96.6% versus the issue price).
Frequently asked questions
- How many times was the Glenmark Life Sciences Limited IPO subscribed?
- The Glenmark Life Sciences Limited IPO was subscribed 44.17× overall — 36.97× in the QIB category, 122.54× among non-institutional investors, 14.63× in retail.
- What were the Glenmark Life Sciences Limited IPO listing gains?
- Glenmark Life Sciences Limited listed on 6 Aug 2021 at ₹750, closing its first day at ₹748 — a listing gain of +4.0% versus the ₹720 issue price.
- What were the retail allotment odds for the Glenmark Life Sciences Limited IPO?
- Retail was subscribed 14.63×, so a single-lot application had roughly a 6.8% chance of allotment (about 1 in 15), and allotment was finalised on 2 Aug 2021.
- What was the price band and lot size of the Glenmark Life Sciences Limited IPO?
- The price band was ₹695–₹720 per share, with a minimum lot of 20 shares (₹14,400 at the upper band).
- Who were the registrar and lead manager for the Glenmark Life Sciences Limited IPO?
- KFin Technologies Private Limited was the registrar, and Kotak Mahindra Capital was the book-running lead manager.